| Literature DB >> 31278286 |
Fausto A Panizzolo1,2, Gregory M Freisinger3,4,5, Nikos Karavas1,2, Asa M Eckert-Erdheim1,2, Christopher Siviy1,2, Andrew Long1,2, Rebecca A Zifchock6, Michael E LaFiandra7, Conor J Walsh1,2.
Abstract
Different adaptation rates have been reported in studies involving ankle exoskeletons designed to reduce the metabolic cost of their wearers. This work aimed to investigate energetic adaptations occurring over multiple training sessions, while walking with a soft exosuit assisting the hip joint. The participants attended five training sessions within 20 days. They walked carrying a load of 20.4 kg for 20 minutes with the exosuit powered and five minutes with the exosuit unpowered. Percentage change in net metabolic cost between the powered and unpowered conditions improved across sessions from -6.2 ± 3.9% (session one) to -10.3 ± 4.7% (session five), indicating a significant effect associated with training. The percentage change at session three (-10.5 ± 4.5%) was similar to the percentage change at session five, indicating that two 20-minute sessions may be sufficient for users to fully adapt and maximize the metabolic benefit provided by the exoskeleton. Retention was also tested measuring the metabolic reduction five months after the last training session. The percent change in metabolic cost during this session (-10.1 ± 3.2%) was similar to the last training session, indicating that the adaptations resulting in reduced metabolic cost are preserved. These outcomes are relevant when evaluating exoskeletons' performance on naïve users, with a specific focus on hip extension assistance.Entities:
Mesh:
Year: 2019 PMID: 31278286 PMCID: PMC6611879 DOI: 10.1038/s41598-019-45914-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Net metabolic cost calculated during walking with the soft exosuit powered at minutes 9–11 (mid_pow), at minutes 18–20 (late_pow) and unpowered at minutes 23–25 (unpow) across the five testing sessions.
|
|
|
| p-value | |
|---|---|---|---|---|
| [W·kg-1] | [W·kg−1] | [W·kg−1] | ||
| Session 1 | 5.33 ± 0.61 | 5.47 ± 0.52 | 5.84 ± 0.67*§ | 0.002 |
| Session 2 | 5.08 ± 0.57 | 5.24 ± 0.69 | 5.74 ± 0.92*§ | 0.01 |
| Session 3 | 5.15 ± 0.28 | 5.20 ± 0.36 | 5.83 ± 0.60*§ | <0.001 |
| Session 4 | 4.98 ± 0.45 | 4.99 ± 0.35 | 5.56 ± 0.45*§ | <0.001 |
| Session 5 | 4.96 ± 0.39 | 4.98 ± 0.41 | 5.56 ± 0.56*§ | <0.001 |
| Across sessions p-value | 0.15 | 0.034 | 0.584 |
*Represents statistically significant within session differences with mid_pow, §represents statistically significant within session differences with late_pow (p < 0.05). Data are means ± standard deviation.
Figure 1Net metabolic cost exhibited by the participants across the five training sessions (n = 8) and 5-month follow-up of retention (n = 5). Absolute values recorded during walking with the soft exosuit powered at minutes 9–11 (mid_pow), at minutes 18–20 (late_pow) and unpowered at minutes (unpow) and percentage change in metabolic cost for mid_pow and late_pow with respect to unpow. Data are mean ± standard deviation.
Borg scale of perceived exertion during walking with the soft exosuit powered at minutes 9–11 (mid_pow), at minutes 18–20 (late_pow) and unpowered at minutes 23–25 (unpow) across the five testing sessions.
|
|
|
| p-value | |
|---|---|---|---|---|
| Session 1 | 10.8 ± 0.9 | 11.5 ± 1.4* | 12.4 ± 1.1*§ | <0.001 |
| Session 2 | 10.3 ± 1.3 | 11.5 ± 1.4 | 13.0 ± 1.2*§ | <0.001 |
| Session 3 | 10.4 ± 1.3 | 11.1 ± 1.1 | 12.3 ± 1.7*§ | 0.007 |
| Session 4 | 10.5 ± 0.9 | 11.1 ± 1.2 | 12.4 ± 1.4*§ | <0.001 |
| Session 5 | 10.8 ± 1.0 | 11.3 ± 1.0 | 12.3 ± 1.5*§ | <0.001 |
| Across sessions p-value | 0.456 | 0.494 | 0.14 |
*Represents statistically significant within session differences with mid_pow, §represents statistically significant within session differences with late_pow (p < 0.05). Data are means ± standard deviation.
Stride time (seconds) during walking with the soft exosuit powered at min 0–2 (early_pow), min 9–11 (mid_pow), at min 18–20 (late_pow) and unpowered (unpow) across the five testing sessions.
|
|
|
|
| p-value | |
|---|---|---|---|---|---|
| Session 1 | 0.98 ± 0.04 | 1.00 ± 0.05 | 1.00 ± 0.05 | 1.01 ± 0.05^ | 0.0017 |
| Session 2 | 0.98 ± 0.04 | 1.00 ± 0.05 | 1.01 ± 0.06* | 1.02 ± 0.04* | <0.001 |
| Session 3 | 0.99 ± 0.05 | 1.01 ± 0.05 | 1.01 ± 0.05 | 1.02 ± 0.04* | 0.026 |
| Session 4 | 0.98 ± 0.04 | 1.01 ± 0.04* | 1.01 ± 0.04* | 1.01 ± 0.04* | 0.002 |
| Session 5 | 0.99 ± 0.04 | 1.01 ± 0.04* | 1.01 ± 0.05* | 1.01 ± 0.04* | 0.008 |
*Represents statistically significant within session differences with early_pow (p < 0.05). Data are means ± standard deviation.
Figure 2Hip soft exosuit mounted on top of a MOLLE II rucksack, side and back view.
Soft exosuit component mass.
| Components | Mass [g] | |
|---|---|---|
| Textile | Base layer | 222 |
| Waist belt | 435 | |
| Thigh braces | 154 | |
| IMU straps | 90 | |
| Power | Actuation | 3100 |
| Battery pack | 1400 | |
| Total | 5401 |
Peak force calculated during walking with the soft exosuit powered at minutes 0–2 (early_pow) minutes 9–11 (mid_pow), at minutes 18–20 (late_pow) across the five testing sessions for each participant.
| n |
|
|
|
|
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| #1 | 300 ± 33 | 306 ± 36 | 304 ± 35 | 288 ± 44 | 308 ± 34 | 304 ± 33 | 295 ± 35 | 302 ± 33 | 309 ± 31 | 288 ± 34 | 308 ± 28 | 301 ± 34 | 290 ± 38 | 308 ± 37 | 302 ± 36 |
| #2 | 299 ± 27 | 300 ± 26 | 300 ± 28 | 295 ± 24 | 295 ± 23 | 300 ± 19 | 299 ± 24 | 298 ± 19 | 300 ± 24 | 297 ± 21 | 299 ± 20 | 298 ± 20 | 298 ± 23 | 297 ± 19 | 300 ± 23 |
| #3 | 296 ± 25 | 299 ± 20 | 302 ± 22 | 296 ± 25 | 300 ± 23 | 301 ± 22 | 298 ± 22 | 297 ± 22 | 298 ± 21 | 301 ± 23 | 299 ± 21 | 299 ± 18 | 300 ± 23 | 303 ± 19 | 301 ± 20 |
| #4 | 297 ± 35 | 294 ± 37 | 300 ± 34 | 288 ± 32 | 298 ± 23 | 296 ± 27 | 291 ± 25 | 293 ± 26 | 296 ± 29 | 298 ± 25 | 298 ± 27 | 301 ± 27 | 290 ± 28 | 300 ± 30 | 298 ± 38 |
| #5 | 300 ± 44 | 296 ± 48 | 307 ± 35 | 295 ± 41 | 299 ± 33 | 304 ± 36 | 301 ± 36 | 304 ± 33 | 311 ± 32 | 292 ± 33 | 304 ± 32 | 301 ± 30 | 299 ± 30 | 305 ± 25 | 307 ± 26 |
| #6 | 305 ± 26 | 302 ± 37 | 305 ± 34 | 298 ± 31 | 294 ± 33 | 302 ± 26 | 289 ± 35 | 273 ± 45 | 291 ± 37 | 281 ± 35 | 280 ± 36 | 274 ± 41 | 282 ± 41 | 298 ± 36 | 304 ± 33 |
| #7 | 300 ± 32 | 302 ± 31 | 301 ± 28 | 294 ± 32 | 298 ± 28 | 308 ± 31 | 297 ± 30 | 302 ± 29 | 307 ± 27 | 292 ± 34 | 305 ± 34 | 309 ± 33 | 302 ± 31 | 302 ± 25 | 302 ± 32 |
| #8 | 298 ± 36 | 306 ± 32 | 307 ± 29 | 299 ± 28 | 305 ± 34 | 306 ± 38 | 306 ± 33 | 307 ± 29 | 304 ± 31 | 300 ± 33 | 306 ± 34 | 303 ± 27 | 300 ± 27 | 299 ± 37 | 302 ± 28 |
Data are displayed in Newtons as means ± standard deviation.
Figure 3Average assistive force profiles provided at the hip across the gait cycle during min 18–20 (late_pow) for: a representative participant during all the testing sessions (A); all the participants during session one (B) and during session five (C).